Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 7/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 7/20 | 0.42 |
| ▸ | RAB9A | P51151 | 6/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL701423 | 1.00 | CYP2A6 (0.51) | CYP2A6MAPTMAPK1CYP1A2CYP2C19 | |
| SCHEMBL2458423 | 0.84 | CYP2A6 (0.69) | CYP2A6MAPTMAPK1CYP1A2CYP2C19 | |
| SCHEMBL2458425 | 0.84 | CYP2A6 (0.69) | CYP2A6MAPTMAPK1CYP1A2CYP2C19 | |
| SCHEMBL5828295 | 0.81 | NFE2L2 (0.55) | MAPTCYP1A2NPC1RAB9AKMT2A | |
| SCHEMBL5828296 | 0.81 | NFE2L2 (0.55) | MAPTCYP1A2NPC1RAB9AKMT2A | |
| SCHEMBL9833018 | 0.80 | CYP2A6 (0.51) | CYP2A6MAPTMAPK1CYP1A2CYP2C19 | |
| SCHEMBL17433415 | 0.80 | CYP2A6 (0.51) | CYP2A6MAPTMAPK1CYP1A2CYP2C19 | |
| SCHEMBL5828902 | 0.79 | CYP19A1 (0.51) | MAPTMAPK1CYP1A2CYP2C19IDO1 | |
| SCHEMBL5828903 | 0.79 | CYP19A1 (0.51) | MAPTMAPK1CYP1A2CYP2C19IDO1 | |
| SCHEMBL14386993 | 0.77 | MAPT (0.53) | CYP2A6MAPTMAPK1CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2825040-A1 | METHOD FOR PRODUCING BENZAZOLOQUINOLIUM (BQS) SALTS, USING THE COMPOSITION AS CELLULAR MARKERS, AND USING THE BIOLOGICAL ACTIVITY OF THE COMPOSITION. | Zayas, Beatriz (US) | 2015-01-21 | — | — | EP | claimed |
| WO-2013059554-A1 | METHOD FOR PRODUCING BENZAZOLOQUINOLIUM (BQS) SALTS, USING THE COMPOSITION AS CELLULAR MARKERS, AND USING THE BIOLOGICAL ACTIVITY OF THE COMPOSITION. | ZAYAS BEATRIZ (US) | 2013-04-25 | — | — | WO | claimed |
| US-20120129882-A1 | Method for producing benzazoloquinolium (BQs) salts, using the composition as cellular markers, and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (PR) | 2012-05-24 | — | — | US | claimed |
| US-8124770-B2 | Fluorescent cellular markers | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-02-28 | — | — | US | claimed |
| US-20100256378-A1 | FLUORESCENT CELLULAR MARKERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-10-07 | — | — | US | claimed |
| US-20240066023-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2024-02-29 | — | — | US | disclosed |
| US-11786520-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIV ANA G MENDEZ INC (US) | 2023-10-17 | — | — | US | disclosed |
| US-11311531-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIV ANA G MENDEZ INC (US) | 2022-04-26 | — | — | US | disclosed |
| US-20210290615-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2021-09-23 | — | — | US | disclosed |
| US-20200261441-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2020-08-20 | — | — | US | disclosed |
| US-20200246328-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2020-08-06 | — | — | US | disclosed |
| US-10624885-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIV ANA G MENDEZ INC (US) | 2020-04-21 | — | — | US | disclosed |
| US-20180214441-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2018-08-02 | — | — | US | disclosed |
| US-9889128-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | Sistema Universitario Ana G. Mendez (PR) | 2018-02-13 | — | — | US | disclosed |
| US-20180008590-A9 | METHOD FOR PRODUCING BENZAZOLOQUINOLIUM (BQS) SALTS AND USING THE BIOLOGICAL ACTIVITY OF THE COMPOSITION | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2018-01-11 | — | — | US | disclosed |
| US-20170079973-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2017-03-23 | — | — | US | disclosed |
| WO-2016044636-A2 | METHOD FOR PRODUCING BENZAZOLOQUINOLIUM (BQS) SALTS AND USING THE BIOLOGICAL ACTIVITY OF THE COMPOSITION | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2016-03-24 | — | — | WO | disclosed |
| US-9085574-B2 | Method for producing benzazoloquinolium (BQs) salts, using the composition as cellular markers, and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (PR) | 2015-07-21 | — | — | US | disclosed |
| US-20120129882-A1 | Method for producing benzazoloquinolium (BQs) salts, using the composition as cellular markers, and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (PR) | 2012-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11786520-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | AHNAK, RECQL, NBAS | CYP2A6 2547/4885MAPT 4399/4885MAPK1 3918/4885 |
| US-11311531-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | CYP2A6 2387/4885MAPT 4449/4885MAPK1 4061/4885 |
| US-20200246328-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | CYP2A6 2387/4885MAPT 4449/4885MAPK1 4061/4885 |
| US-10624885-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | CYP2A6 2387/4885MAPT 4449/4885MAPK1 4061/4885 |
| US-20180008590-A9 | METHOD FOR PRODUCING BENZAZOLOQUINOLIUM (BQS) SALTS AND USING THE BIOLOGICAL ACTIVITY OF THE COMPOSITION | RECQL, AHNAK, NDUFS1 | CYP2A6 2387/4885MAPT 4449/4885MAPK1 4061/4885 |
| US-20210290615-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | AHNAK, RECQL, NBAS | CYP2A6 2547/4885MAPT 4399/4885MAPK1 3918/4885 |
| US-20100256378-A1 | FLUORESCENT CELLULAR MARKERS | AIFM1, CASP3, BAX | CYP2A6 4465/4885MAPT 3510/4885MAPK1 3253/4885 |
| US-20120129882-A1 | Method for producing benzazoloquinolium (BQs) salts, using the composition as cellular markers, and using the biological activity of the composition | IMMT, BAX, BCL2 | CYP2A6 3594/4885MAPT 3793/4885MAPK1 3703/4885 |
| US-20180214441-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | CYP2A6 2387/4885MAPT 4449/4885MAPK1 4061/4885 |
| US-20240066023-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | AHNAK, RECQL, NBAS | CYP2A6 2547/4885MAPT 4399/4885MAPK1 3918/4885 |
| US-20200261441-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | CYP2A6 2387/4885MAPT 4449/4885MAPK1 4061/4885 |
| US-20170079973-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | CYP2A6 2387/4885MAPT 4449/4885MAPK1 4061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.